logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
8/3/2021 4:04:46 PM Neurocrine Biosciences Q2 EPS $0.43 Vs. $0.81 Year Ago
5/5/2021 4:06:26 PM Neurocrine Biosciences Q1 GAAP EPS $0.33 Vs $0.39 Last Year
5/3/2021 8:33:54 AM Neurocrine Biosciences Supports Mental Health Month And Tardive Dyskinesia Awareness Week
4/16/2021 9:01:25 AM Neurocrine Biosciences Appoints Johanna Mercier To Its Board
3/20/2021 11:29:29 AM Neurocrine Biosciences To Present New Data Analyses For Crinecerfont In Classic Congenital Adrenal Hyperplasia
3/2/2021 7:36:35 AM Neurocrine Biosciences Says Luvadaxistat Did Not Meet Primary Endpoint In Phase II INTERACT Study
2/4/2021 4:04:24 PM Neurocrine Biosciences Q4 EPS $3.58 Vs. $0.35 Year Ago
1/8/2021 7:33:49 AM Neurocrine Biosciences Preliminary 2020 INGREZZA Net Product Sales And TRx Both Up 32% To About $993 Mln
11/10/2020 7:14:30 AM William Blair Is Cutting Neurocrine Biosciences Inc (NBIX) FY22 Rev. Estimate To 1.44 Billion From 1.87 Billion